Approval · Notice of Compliance 28045 · 2022
EVRA: Notice of Compliance 28045
Issued April 29, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28045
- Date
- April 29, 2022
- Company
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EVRA | 02248297 | Marketed |
Medicinal ingredients
- ETHINYL ESTRADIOL 35 MCG per UNIT
- NORELGESTROMIN 200 MCG per UNIT